9. Jenkins DJ et al. Possible benefit of nuts in type 2 diabetes. J. Nutr. 2008 Sep; 138(9):1752S–1756S.
10. Hernandez-Alonso P et al. Beneficial effect of pistachio consumption on glucose metabolism, insulin resistance, inflammation, and related metabolic risk markers: a randomized clinical trial. 2014 Aug 14. doi: 10.2337/dc14–1431. [Epub ahead of print] Accessed 2015 Apr 6.
11. Walton AG. All sugared up: the best and worst breakfast cereals for kids. Forbes [Internet]. 2014 May 15. Available at: http://www.forbes.com/sites/alicegwalton/2014/05/15/all-sugared-up-the-best-and-worst-breakfast-cereals-for-kids/. Accessed 2015 Apr 12.
12. Fernandez ML. Dietary cholesterol provided by eggs and plasma lipoproteins in healthy populations. Curr Opin Clin Nutr Metab Care. 2006 Jan; 9(1):8–12.
13. Mutungi G et al. Eggs distinctly modulate plasma carotenoid and lipoprotein subclasses in adult men following a carbohydrate-restricted diet. J Nutr Biochem. 2010 Apr; 21(4):261–7. doi: 10.1016/j.jnutbio.2008.12.011. Epub 2009 Apr 14.
14. Shin JY, Xun P, Nakamura Y, He K. Egg consumption in relation to risk of cardiovascular disease and diabetes: a systematic review and meta-analysis. Am J Clin Nutr. 2013 Jul; 98(1):146–59.
15. Rong Y et al. Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies. BMJ. 2013; 346:e8539. doi: 10.1136/bmj.e8539. Accessed 2015 Apr 6.
16. Cordain L et al. Influence of moderate chronic wine consumption on insulin sensitivity and other correlates of syndrome X in moderately obese women. Metabolism. 2000 Nov; 49(11):1473–8.
17. Cordain L et al. Influence of moderate chronic wine consumption on insulin sensitivity and other correlates of syndrome X in moderately obese women. Metabolism. 2000 Nov; 49(11):1473–8.
18. Napoli R et al. Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients. Metabolism. 2005 Mar; 54(3):306–13.
19. Huxley R et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med. 2009 Dec 14; 169(22):2053–63.
20. Gómez-Ruiz JA, Leake DS, Ames JM. In vitro antioxidant activity of coffee compounds and their metabolites. J Agric Food Chem. 2007 Aug 22; 55(17):6962–9.
21. Milder IE, Arts I, Cvan de Putte B, Venema DP, Hollman PC. Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and metairesinol. Br J Nutr. 2005 Mar; 93(3):393–402.
22. Clifford MN. Chlorogenic acids and other cinnamates: nature, occurrence and dietary burden. J Sci Food Agric. 1999; 79(5):362–72.
23. Huxley R et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med. 2009 Dec 14; 169(22):2053–63.
24. Van Dieren S et al. Coffee and tea consumption and risk of type 2 diabetes. Diabetologia. 2009 Dec; 52(12):2561–9.
25. Odegaard AO et al. Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr. 2008 Oct; 88(4):979–85.
26. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012 May 17; 366(20):1891–904.
27. Lopez-Garcia E, van Dam RM, Li TY, Rodriguez-Artalejo F, Hu FB. The relationship of coffee consumption with mortality. Ann Intern Med. 2008 Jun 17; 148(2):904–14.
28. Eskelinen MH, Kivipelto M. Caffeine as a protective factor in dementia and Alzheimer’s disease. J Alzheimers Dis. 2010; 20 Suppl 1:167–74.
29. Santos C et al. Caffeine intake and dementia: systematic review and meta-analysis. J Alzheimers Dis. 2010; 20 Suppl 1:S187–204. doi: 10.3233/JAD-2010–091387. Accessed 2015 Apr 6.
30. Hernan MA et al. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s disease. Ann Neurol. 2002 Sep; 52(3):276–84.
31. Ross GW et al. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA. 2000 May; 283(20):2674–9.
32. Klatsky AL et al. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med. 2006 Jun 12; 166(11):1190–5.
33. Klatsky AL et al. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med. 2006 Jun 12; 166(11):1190–5.
34. Kobayashi Y, Suzuki M, Satsu H et al. Green tea polyphenols inhibit the sodiumdependent glucose transporter of intestinal epithelial cells by a competitive mechanism. J Agric Food Chem. 2000 Nov; 48(11):5618–23.
35. Crespy V, Williamson GA. A review of the health effects of green tea catechins in in vivo animal models. J Nutr. 2004 Dec; 134(12 suppl):3431S–3440S.
36. Cabrera C et al. Beneficial effects of green tea: a review. J Am Coll Nutr. 2006 Apr; 25(2):79–99.
37. Hursel, R, Westerterp-Plantenga MS. Catechin- and caffeine-rich teas for control of body weight in humans. Am J Clin Nutr. 2013 Dec; 98(6):1682S–93S.
38. Dulloo AG et al. Green tea and thermogenesis: interactions between catechinpolyphenols, caffeine and sympathetic activity. Inter J Obesity. 2000 Feb; 24(2):252–8.
39. Venables MC et al. Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans. Am J Clin Nutr. 2008 Mar; 87(3):778–84.
40. Dulloo AG et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr. 1999 Dec; 70(6):1040–5.
41. Koo MWL, Cho CH. Pharmacological effects of green tea on the gastrointestinal system. Eur J Pharmacol. 2004 Oct 1; 500(1–3):177–85.
42. Hursel R Viechtbauer W, Westerterp-Plantenga, MS. The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes (Lond). 2009 Sep; 33(9):956–61. doi: 10.1038/ijo.2009.135. Epub 2009 Jul 14. Accessed 6 Apr 2015.
43. Van Dieren S et al. Coffee and tea consumption and risk of type 2 diabetes. Diabetologia. 2009 Dec; 52(12):2561–9.
44. Odegaard, AO et al. Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr. 2008 Oct; 88(4):979–85.
45. Patrick L, Uzick M. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature. Alternative Medicine Review. 2001 Jun; 6(3):248–71.
46. Aviram M, Eias K. Dietary olive oil reduces low-density lipoprotein uptake by macrophages and decreases the susceptibility of the lipoprotein to undergo lipid peroxidation. Ann Nutr Metab. 1993; 37(2):75–84.
47. Smith RD et al. Long-term monounsaturated fatty acid diets reduce platelet aggregation in healthy young subjects. Br J Nutr. 2003 Sep; 90(3):597–606.
48. Ferrara LA et al. Olive oil and reduced need for antihypertensive medications. Arch Intern Med. 2000 Mar 27; 160(6):837–42.
49. Martínez-González MA et al. Olive oil consumption and risk of CHD and/or stroke: a meta-analysis of case-control, cohort and intervention studies. Br J Ntru. 2014 Jul; 112(2):248–59.
50. Chen M, Pan A, Malik VS, Hu FB. Effects of dairy intake on body weight and fat: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2012 Oct; 96(4):735–47.
51. Mozaffarian, D et al. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med. 2010 Dec 21; 153(12):790–9.
52. Hyman M. The super fiber that controls your appetite and blood sugar. Huffington Post [Internet]. 2010 May 29 (updated 2013 Nov 11). Available from: http://www.huffingtonpost.com/dr-mark-hyman/fiber-health-the-super-fi_b_594153.html. Accessed 2015 Apr 6.
53. Sugiyama M et al. Glycemic index of single and mixed meal foods among common Japanese foods with white rice as a reference food. Euro J Clin Nutr. 2003 Jun; 57(6):743–52. doi:10.1038/sj.ejcn.1601606. Accessed 2015 Apr 6.
1. Arbesmann R. Fasting and prophecy in pagan and Christian antiquity. Traditio. 1951; 7:1–71.
2. Lamine F et al. Food intake and high density lipoprotein cholesterol levels changes during Ramadan fasting in healthy young subjects. Tunis Med. 2006 Oct; 84(10):647–650.
3. Felig P. Starvation. In: DeGroot LJ, Cahill GF Jr et al., editors. Endocrinology: Vol 3. New York: Grune & Stratton; 1979. pp. 1927–40.
4. Coffee CJ, Quick look: metabolism. Hayes Barton Press; 2004. p. 169.
5. Owen OE, Felig P. Liver and kidney metabolism during prolonged starvation. J Clin Invest. 1969 Mar; 48:574–83.
6. Merrimee TJ, Tyson JE. Stabilization of plasma glucose during fasting: normal variation in two separate studies. N Engl J Med. 1974 Dec 12; 291(24):1275–8.
7. Heilbronn LK. Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr. 2005; 81:69–73.
8. Halberg N. Effect of intermittent fasting and refeeding on insulin action in healthy men. J Appl Physiol. 1985 Dec; 99(6):2128–36.
9. Rudman D et al. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990 Jul 5; 323(1):1–6.
10. Ho KY et al. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest. 1988 Apr; 81(4):968–75.
11. Drenick EJ. The effects of acute and prolonged fasting and refeeding on water, electrolyte, and acid-base metabolism. In: Maxwell MH, Kleeman CR, editors. Clinical disorders of fluid and electrolyte metabolism. 3rd ed. New York: McGraw-Hill; 1979.
12. Kerndt PR et al. Fasting: the history, pathophysiology and complications. West J Med. 1982 Nov; 137(5):379–99.
13. Stewart WK, Fleming LW. Features of a successful therapeutic fast of 382 days’ duration. Postgrad Med J. 1973 Mar; 49(569):203–9.